Inimmune participates in the development of an innovative intranasal influenza vaccine
Inimmune is part of a European consortium, led by the Medical University of Vienna, whose goal is to develop a next-generation vaccine against influenza strains with pandemic potential The consortium aims to be selected under the European Commission’s EU4Health programme Girona, Spain — 24 November 2025 — – Inimmune, a leading clinical stage biotech company […]
